Stem bromelain-induced macrophage apoptosis and activation curtail mycobacterium tuberculosis persistence

Journal of Infectious Diseases

Volumn 206, Issue 3, 2012, Pages 366-376

  Mahajan, Sahil ^a   Chandra, Vemika ^a   Dave, Sandeep ^a   Nanduri, Ravikanth ^a   Gupta, Pawan ^a  

^a INSTITUTE OF MICROBIAL TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; BROMELAIN; CASPASE 3; CASPASE 9; CD36 ANTIGEN; FREE RADICAL; GLUTATHIONE; HYDROGEN PEROXIDE; INTERLEUKIN 10; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE; PEROXYNITRITE; PROTEIN BAX; PROTEIN BCL 2; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; STEM BROMELAIN; SUPEROXIDE; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBACTERIAL ACTIVITY; APOPTOSIS; ARTICLE; BACTERIAL LOAD; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DOWN REGULATION; FOAM CELL; HUMAN; HUMAN CELL; INNATE IMMUNITY; MACROPHAGE ACTIVATION; MALE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; UPREGULATION;

AMINO ACID SEQUENCE; ANANAS; ANIMALS; ANTIGENS, CD36; ANTITUBERCULAR AGENTS; APOPTOSIS; BROMELAINS; CELLS, CULTURED; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE ANNOTATION; MYCOBACTERIUM TUBERCULOSIS; REACTIVE OXYGEN SPECIES;

EID: 84863953247     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis354     Document Type: Article

References (48)

1. Pieters J. Mycobacterium tuberculosis and the macrophage: maintaining a balance. Cell Host Microbe 2008; 3:399-407.
2. Chan ED, Iseman MD. Multidrug-resistant and extensively drugresistant tuberculosis: a review. Curr Opin Infect Dis 2008; 21:587-95.
3. Johnston JC, Shahidi NC, Sadatsafavi M, Fitzgerald JM. Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS One 2009; 4:e6914.
4. Condrau F. "Who is the captain of all these men of death?": the social structure of a tuberculosis sanatorium in postwar Germany. J Interdiscip Hist 2001; 32:243-62.
5. Waters WR, Nonnecke BJ, Rahner TE, Palmer MV, Whipple DL, Horst RL. Modulation of Mycobacterium bovis-specific responses of bovine peripheral blood mononuclear cells by 1,25-dihydroxyvitamin D(3). Clin Diagn Lab Immunol 2001; 8:1204-12.
6. Hewison M. Antibacterial effects of vitamin D. Nat Rev Endocrinol 2011; 7:337-45.
7. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311:1770-3.
8. Chen LW, Cheng MJ, Peng CF, Chen IS. Secondary metabolites and antimycobacterial activities from the roots of Ficus nervosa. Chem Biodivers 2010; 7:1814-21.
9. Mitscher LA, Baker W. Tuberculosis: a search for novel therapy starting with natural products. Med Res Rev 1998; 18:363-74.
10. McGaw LJ, Lall N, Meyer JJ, Eloff JN. The potential of South African plants against Mycobacterium infections. J Ethnopharmacol 2008; 119:482-500.
11. Gautam R, Saklani A, Jachak SM. Indian medicinal plants as a source of antimycobacterial agents. J Ethnopharmacol 2007; 110:200-34.
12. Dave S, Dkhar HK, Singh MP, et al. Hexafluoroisopropanol-induced helix-sheet transition of stem bromelain: correlation to function. Int J Biochem Cell Biol 2010; 42:938-47.
13. Maurer HR. Bromelain: biochemistry, pharmacology and medical use. Cell Mol Life Sci 2001; 58:1234-45.
14. Hale LP, Haynes BF. Bromelain treatment of human T cells removes CD44, CD45RA, E2/MIC2, CD6, CD7, CD8, and Leu 8/LAM1 surface molecules and markedly enhances CD2-mediated T cell activation. J Immunol 1992; 149:3809-16.
15. Engwerda CR, Andrew D, Murphy M, Mynott TL. Bromelain activates murine macrophages and natural killer cells in vitro. Cell Immunol 2001; 210:5-10.
16. Karlsen M, Hovden AO, Vogelsang P, Tysnes BB, Appel S. Bromelain treatment leads to maturation of monocyte-derived dendritic cells, but cannot replace PGE(2) in a cocktail of IL-1beta, IL-6, TNF-alpha and PGE(2). Scand J Immunol 2011; 74:135-43.
17. Bhui K, Prasad S, George J, Shukla Y. Bromelain inhibits COX-2 expression by blocking the activation of MAPK regulated NF-kappa B against skin tumor-initiation triggering mitochondrial death pathway. Cancer Lett 2009; 282:167-76.
18. Velmurugan K, Chen B, Miller JL, et al. Mycobacterium tuberculosis nuoG is a virulence gene that inhibits apoptosis of infected host cells. PLoS Pathog 2007; 3:e110.
19. Fratazzi C, Arbeit RD, Carini C, et al. Macrophage apoptosis in mycobacterial infections. J Leukoc Biol 1999; 66:763-4.
20. Shin DM, Jeon BY, Lee HM, et al. Mycobacterium tuberculosis eis regulates autophagy, inflammation, and cell death through redoxdependent signaling. PLoS Pathog 2010; 6:e1001230.
21. Chan J, Xing Y, Magliozzo RS, Bloom BR. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 1992; 175:1111-22.
22. Peyron P, Vaubourgeix J, Poquet Y, et al. Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog 2008; 4:e1000204.
23. Neyrolles O, Hernandez-Pando R, Pietri-Rouxel F, et al. Is adipose tissue a place for Mycobacterium tuberculosis persistence? PLoS One 2006; 1:e43.
24. Tang H, Cao W, Kasturi SP, et al. The T helper type 2 response to cysteine proteases requires dendritic cell-basophil cooperation via ROS-mediated signaling. Nat Immunol 2010; 11:608-17.
25. Donnelly S, O'Neill SM, Stack CM, et al. Helminth cysteine proteases inhibit TRIF-dependent activation of macrophages via degradation of TLR3. J Biol Chem 2010; 285:3383-92.
26. Guimaraes-Ferreira CA, Rodrigues EG, Mortara RA, et al. Antitumor effects in vitro and in vivo and mechanisms of protection against melanoma B16F10-Nex2 cells by fastuosain, a cysteine proteinase from Bromelia fastuosa. Neoplasia 2007; 9:723-33.
27. Rose B, Herder C, Loffler H, et al. Dose-dependent induction of IL-6 by plant-derived proteases in vitro. Clin Exp Immunol 2006; 143:85-92.
28. Targoni OS, Tary-Lehmann M, Lehmann PV. Prevention of murine EAE by oral hydrolytic enzyme treatment. J Autoimmun 1999; 12:191-8.
29. Garcia-Touchard A, Henry TD, Sangiorgi G, et al. Extracellular proteases in atherosclerosis and restenosis. Arterioscler Thromb Vasc Biol 2005; 25:1119-27.
30. Pieters J, Gatfield J. Hijacking the host: survival of pathogenic mycobacteria inside macrophages. Trends Microbiol 2002; 10:142-6.
31. Kelly DM, ten Bokum AM, O'Leary SM, O'Sullivan MP, Keane J. Bystander macrophage apoptosis after Mycobacterium tuberculosis H37Ra infection. Infect Immun 2008; 76:351-60.
32. Duan L, Gan H, Arm J, Remold HG. Cytosolic phospholipase A2 participates with TNF-alpha in the induction of apoptosis of human macrophages infected with Mycobacterium tuberculosis H37Ra. J Immunol 2001; 166:7469-76.
33. Lee J, Remold HG, Ieong MH, Kornfeld H. Macrophage apoptosis in response to high intracellular burden of Mycobacterium tuberculosis is mediated by a novel caspase-independent pathway. J Immunol 2006; 176:4267-74.
34. Kalra N, Bhui K, Roy P, et al. Regulation of p53, nuclear factor kappaB and cyclooxygenase-2 expression by bromelain through targeting mitogen-activated protein kinase pathway in mouse skin. Toxicol Appl Pharmacol 2008; 226:30-7.
35. Bhui K, Tyagi S, Prakash B, Shukla Y. Pineapple bromelain induces autophagy, facilitating apoptotic response in mammary carcinoma cells. Biofactors 2010; 36:474-82.
36. Grimm S, Bauer MK, Baeuerle PA, Schulze-Osthoff K. Bcl-2 downregulates the activity of transcription factor NF-kappaB induced upon apoptosis. J Cell Biol 1996; 134:13-23.
37. Zhang J, Jiang R, Takayama H, Tanaka Y. Survival of virulent Mycobacterium tuberculosis involves preventing apoptosis induced by Bcl-2 upregulation and release resulting from necrosis in J774 macrophages. Microbiol Immunol 2005; 49:845-52.
38. Dlugosz PJ, Billen LP, Annis MG, et al. Bcl-2 changes conformation to inhibit Bax oligomerization. EMBO J 2006; 25:2287-96.
39. Desser L, Rehberger A. Induction of tumor necrosis factor in human peripheral-blood mononuclear cells by proteolytic enzymes. Oncology 1990; 47:475-7.
40. Desser L, Rehberger A, Paukovits W. Proteolytic enzymes and amylase induce cytokine production in human peripheral blood mononuclear cells in vitro. Cancer Biother 1994; 9:253-63.
41. Desser L, Rehberger A, Kokron E, Paukovits W. Cytokine synthesis in human peripheral blood mononuclear cells after oral administration of polyenzyme preparations. Oncology 1993; 50:403-7.
42. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8:958-69.
43. Wen J, You KR, Lee SY, Song CH, Kim DG. Oxidative stress-mediated apoptosis. The anticancer effect of the sesquiterpene lactone parthenolide. J Biol Chem 2002; 277:38954-64.
44. Brakebusch M, Wintergerst U, Petropoulou T, et al. Bromelain is an accelerator of phagocytosis, respiratory burst and killing of Candida albicans by human granulocytes and monocytes. Eur J Med Res 2001; 6:193-200.
45. Ehrt S, Schnappinger D. Mycobacterium tuberculosis virulence: lipids inside and out. Nat Med 2007; 13:284-5.
46. Hart PD, Armstrong JA, Brodaty E. Calixarenes with host-mediated potency in experimental tuberculosis: further evidence that macrophage lipids are involved in their mechanism of action. Infect Immun 1996; 64:1491-3.
47. Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 1998; 93:229-40.
48. Kunjathoor VV, Febbraio M, Podrez EA, et al. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J Biol Chem 2002; 277:49982-8.